Desjardins Global Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$66.8K Buy
903
+262
+41% +$17.2K 0.01% 503
2023
Q3
$43.7K Buy
641
+44
+7% +$3.73K ﹤0.01% 551
2023
Q2
$56.1K Buy
597
+96
+19% +$7.49K 0.01% 527
2023
Q1
$34K Sell
501
-48
-9% -$3.08K ﹤0.01% 541
2022
Q4
$27K Buy
549
+163
+42% +$6.66K ﹤0.01% 458
2022
Q3
$12K Sell
386
-126
-25% -$5.2K ﹤0.01% 468
2022
Q2
$20K Buy
+512
New +$27.4K ﹤0.01% 463

Other funds holding EXAS

Desjardins Global Asset Management's EXAS Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Exact Sciences (EXAS) stake by 41% in Q4 2023, buying an estimated $17.2K and bringing the position to 903 shares worth $66.8K. The position accounts for 0.01% of the portfolio, ranked #503.

Desjardins Global Asset Management first reported a position in EXAS in Q2 2022 and has held it in 7 quarters since. 646 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Desjardins Global Asset Management held 903 shares of Exact Sciences worth $66.8K as of Q4 2023.
  • Desjardins Global Asset Management bought 262 Exact Sciences shares in Q4 2023, an estimated $17.2K.
  • Exact Sciences made up 0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #503 holding.
  • Desjardins Global Asset Management first reported a position in Exact Sciences in Q2 2022 and has held it in 7 quarters since.
  • 646 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.